Document Detail


Hyperuricemia and gout: an update.
MedLine Citation:
PMID:  6895439     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Gout may be a primary or a secondary disorder. In both types of gout, overproduction or underexcretion of uric acid, or a combination of these abnormalities, may be the underlying mechanism. Controversy exists over the need for treatment of asymptomatic hyperuricemia. Treatment of tophi requires use of both uricosurics and allopurinol. A xanthine oxidase inhibitor is the drug of choice for patients with uric acid stones and for those with renal insufficiency.
Authors:
A K Khachadurian
Related Documents :
1254369 - Drug flashbacks. ii. some additional findings.
7261949 - The risks of asymptomatic hyperuricaemia and the use of uricosuric diuretics.
6484299 - Stereo-specificity of diuretic receptors in the nephron: a study of the enantiomers of ...
8318609 - The functional properties of hemoglobin modified with mellitic dianhydride: possible ap...
16602719 - Influence of peg endgroup and molecular weight on its reactivity for lipase-catalyzed p...
5635159 - Anhydrous uric acid: nature and occurrence of a new form of urinary calculi.
6563919 - Analyses of lysophosphatidic acids by gas chromatography mass spectrometry without hydr...
10334499 - Ampa/kainate-related mechanisms contribute to convulsant and proconvulsant effects of 3...
1158329 - The conversion of l-phenylalanine into benzoic acid on the thylakoid membrane of higher...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American family physician     Volume:  24     ISSN:  0002-838X     ISO Abbreviation:  Am Fam Physician     Publication Date:  1981 Dec 
Date Detail:
Created Date:  1982-01-28     Completed Date:  1982-01-28     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  1272646     Medline TA:  Am Fam Physician     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  143-8     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Allopurinol / therapeutic use
Female
Gout* / diet therapy,  metabolism,  prevention & control
Humans
Kidney / metabolism
Kidney Diseases / blood,  drug therapy,  metabolism
Male
Metabolic Clearance Rate
Middle Aged
Uric Acid / blood*,  metabolism,  urine
Uricosuric Agents / therapeutic use
Xanthine Oxidase / antagonists & inhibitors
Chemical
Reg. No./Substance:
0/Uricosuric Agents; 315-30-0/Allopurinol; 69-93-2/Uric Acid; EC 1.17.3.2/Xanthine Oxidase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effect of molsidomin on the arterial windkessel (author's transl)
Next Document:  Hypothyroidism after thyroidectomy for Graves' disease.